Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery

OBJECTIVES: The ongoing COVID-19 pandemic comprises a total of more than 2,350,000 cases and 160,000 deaths. The interest in anti-coronavirus drug development has been limited so far and effective methods to prevent or treat coronavirus infections in humans are still lacking. Urgent action is needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Plaze, M., Attali, D., Petit, A.-C., Blatzer, M., Simon-Loriere, E., Vinckier, F., Cachia, A., Chrétien, F., Gaillard, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: L'Encéphale, Paris. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188634/
https://www.ncbi.nlm.nih.gov/pubmed/32387014
http://dx.doi.org/10.1016/j.encep.2020.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188634/
https://www.ncbi.nlm.nih.gov/pubmed/32387014
http://dx.doi.org/10.1016/j.encep.2020.04.010

Ejemplares similares